Open programs1
Research Funding Opportunities
The ALS Association's Hoffman ALS Clinical Trial Awards Program supports early- to mid-stage (phase 1 or 2a) biomarker-driven clinical trials of novel or repurposed ALS therapeutics (disease‑modifying or symptomatic) and imaging tracer development, providing up to $1,000,000 total funding over 2–3 years.
- Deadline
- Not listed
- Amount
- $150,000
Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.